Welcome to our dedicated page for Blackbaud SEC filings (Ticker: BLKB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blackbaud, Inc. (NASDAQ: BLKB) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a software company dedicated to powering social impact. These SEC filings include annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with other exhibits and technical materials.
Current reports on Form 8-K are used by Blackbaud to disclose material events such as the release of unaudited quarterly financial results. For example, recent 8-K filings have attached press releases covering revenue, operating margins, cash flow metrics, non-GAAP financial measures and commentary from company leadership. These filings also describe how Blackbaud uses non-GAAP metrics like adjusted EBITDA, free cash flow and adjusted free cash flow to analyze its operating performance.
Investors reviewing Blackbaud’s 10-K and 10-Q filings can find information on its software portfolio for fundraising, nonprofit financial management, digital giving, grantmaking, corporate social responsibility and education management, as well as risk factors, accounting policies and segment-level details. Over time, these reports help clarify how the company’s AI roadmap, product innovation and capital allocation strategies, including stock repurchase programs, are reflected in its financial statements.
On this page, Stock Titan surfaces Blackbaud’s SEC filings as they become available from EDGAR and pairs them with AI-powered summaries. These summaries are designed to highlight key points from lengthy documents—such as major changes in guidance, updates to non-GAAP definitions, or revisions to prior-period financial statements—so readers can quickly understand what has changed without reading every line. Users can also review insider-related filings like Form 4 when available, to see reported transactions by directors and officers in Blackbaud’s common stock.
BLKB filed a Rule 144 notice reporting a proposed sale of Common Stock through Merrill Lynch One Bryant Park. The filing lists 23,745 shares with an aggregate amount of $1,175,614.95 and an identifier 47834179, dated 02/18/2026, on NASDAQ.
The submission also lists restricted stock unit vesting events and corresponding Common Stock amounts: 7,990 shares (vested 02/13/2023), 6,251 shares (vested 02/21/2024), 6,777 shares (vested 02/19/2025), and 2,727 shares (vested 02/18/2025), each labeled as Compensatory Payment.
Blackbaud, Inc. reported its fourth quarter and full-year 2025 results, showing a strong profitability turnaround and solid organic growth despite headline revenue pressure from the EVERFI divestiture. For 2025, GAAP revenue was $1.13 billion, down 2.3%, while non-GAAP organic revenue grew 5.5%. GAAP net income reached $115.0 million, or $2.37 diluted EPS, compared with a prior-year loss, and non-GAAP diluted EPS rose to $4.45. Non-GAAP adjusted EBITDA was $405.3 million with a 35.9% margin and a Rule of 40 score of 41.4%. The company issued 2026 guidance for GAAP revenue of $1.173–$1.179 billion, non-GAAP adjusted EBITDA of $430–$438 million, non-GAAP diluted EPS of $5.15–$5.25, and non-GAAP free cash flow of $280–$290 million. Blackbaud also highlighted a reauthorized and expanded $1 billion stock repurchase program, with about $961 million remaining as of December 31, 2025, and plans for 2026 repurchases equal to 5–10% of shares outstanding at year-end 2025.
Blackbaud Inc. (BLKB) reported an insider stock transaction by a company director. On 11/21/2025, the director sold 1,600 shares of Blackbaud common stock in an open market transaction coded "S" at a price of $56.49 per share. After this sale, the director directly beneficially owns 6,366 shares of Blackbaud common stock.
Blackbaud (BLKB) President and CEO, who also serves as a Director, reported open-market sales totaling 15,000 shares over three days. The transactions occurred on November 4–6, 2025 at weighted average prices spanning $57.2983 to $63.291, with individual trades executed within the disclosed price ranges.
Following these sales, the reporting person directly beneficially owns 372,985 shares. Reported tranches included sales such as 3,952 shares at a weighted average price of $62.1795 and 3,692 shares at a weighted average price of $57.2983, among others.
Blackbaud (BLKB) reported an insider equity update via an amended Form 4. The company’s EVP and Chief Operating Officer recorded equity changes tied to performance RSUs on 08/05/2025.
On that date, 3,400 shares of common stock were acquired at $0 upon PRSU vesting, following the Compensation Committee’s determination based on performance goals for the period ended December 31, 2024, subject to continued employment. To cover tax liabilities from a separate PRSU vesting, 1,549 shares were forfeited to the issuer at $63.12.
This Form 4/A corrects an earlier filing that had inadvertently reported 928 shares as forfeited. After the reported transactions, the officer beneficially owned 109,985 shares directly.
Blackbaud reported Q3 2025 results showing stronger profitability on slightly lower revenue. Revenue was $281.1 million versus $286.6 million a year ago, while income from operations rose to $54.6 million from $41.1 million. Net income increased to $47.5 million from $18.3 million, with diluted EPS of $0.98 versus $0.35.
The effective tax rate improved to (15.7)%, primarily from a valuation allowance reduction and the One Big Beautiful Bill Act’s treatment of U.S. R&D expensing. Year‑to‑date cash from operations was $207.5 million. Total debt was $1.07 billion with a 5.61% weighted average effective rate. Deferred revenue totaled $384.9 million.
The company repurchased 459,528 shares for $30.1 million in Q3 and $130.2 million year‑to‑date, with $514.4 million remaining under its authorization. Blackbaud revised prior periods to correct a $15.5 million deferred tax liability error, which was not material to those periods. Customer constituent class actions related to the 2020 security incident are resolved and closed; certain insurance carrier subrogation appeals remain pending.
Blackbaud, Inc. (BLKB) furnished an 8-K announcing it issued a press release reporting unaudited financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1. The company states this information is being furnished and shall not be deemed “filed” under Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly set forth.
The Vanguard Group filed an amendment to a Schedule 13G reporting ownership of 5,516,432 shares of Blackbaud Inc. common stock, equal to 11.37% of the class as of 09/30/2025. Vanguard reports 0 shares with sole voting power and 258,949 shares with shared voting power, while retaining 5,209,213 shares with sole dispositive power and 307,219 shares with shared dispositive power.
The filing states these holdings are managed in the ordinary course of business and are not intended to change or influence control of the issuer. The filing identifies Vanguard as an investment adviser organized in Pennsylvania and signed by Ashley Grim on 10/06/2025.
Director Deneen DeFiore reported a sale of 4,000 shares of Blackbaud, Inc. (BLKB) on 08/29/2025 at a price of $66.6114 per share, reducing her direct holdings to 10,069 shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing discloses the transaction details required under Section 16 and shows the director disposed of roughly 28.4% of her previously held shares.
Blackbaud, Inc. (BLKB) Form 144 notice: An officer or other person affiliated with the company reported a proposed sale of 4,000 common shares through Merrill Lynch, valued at $266,445.60, with an approximate sale date of 08/29/2025 on NASDAQ. The shares were acquired on 08/01/2023 via vesting of a stock award from Blackbaud, Inc., and the acquisition was compensatory in nature. The filer reports 48,509,032 shares outstanding, so the proposed sale represents a very small fraction of total shares outstanding. No sales by the filer in the past three months were reported. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.